Conceptualisation and development of the Leg Activity Measure (LegA) for patient and carer reported assessment of activity (function) in the paretic leg in people with acquired brain injury by Ashford, Stephen et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1002/pri.1660
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Ashford, S., Jackson, D. M., Mahaffey, P., Vanderstay, R., & Turner-Stokes, L. F. (2016). Conceptualisation and
development of the Leg Activity Measure (LegA) for patient and carer reported assessment of activity (function)
in the paretic leg in people with acquired brain injury. PHYSIOTHERAPY RESEARCH INTERNATIONAL.
10.1002/pri.1660
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 18. Feb. 2017
Development of the Leg Activity Measure (LegA) 
 
 1 
Conceptualisation and development of the Leg Activity Measure (LegA) for 
patient and carer reported assessment of activity in the paretic leg 
 
 
Stephen Ashford1, 2 PhD MSc MCSP 
Clinical Lecturer and Consultant Physiotherapist 
 
Diana Jackson2 PhD MSc MCSP 
Senior Research Fellow 
 
Patrick Mahaffey1 
Patient Expert 
 
Roxana Vanderstay2 PhD  
Lecturer 
 
Lynne Turner-Stokes1, 2 DM FRCP 
Herbert Dunhill Chair of Rehabilitation and Director Regional Rehabilitation Unit 
 
 
1 Regional Rehabilitation Unit, Northwick Park Hospital 
2 King’s College London, School of Medicine, Department of Palliative Care, Policy 
and Rehabilitation 
 
Address for correspondence: Stephen Ashford, Regional Rehabilitation Unit, 
Northwick Park Hospital, Watford Road, Harrow, Middlesex HA1 3UJ, UK 
Tel: +44 (0) 20 8869 2800 
Fax: +44 (0) 20 8869 2803 
Email: Stephen.Ashford@nhs.net 
 
 
Keywords:  function, lower limb, leg, outcome measurement. 
Development of the Leg Activity Measure (LegA) 
 
 2 
 
Abstract 
 
Objective 
To develop a patient reported outcome measure (PROM) of active and passive function 
in the paretic lower limb.   
Methods 
Potential items for inclusion were identified through a) systematic review and analysis 
of existing measures and b) analysis of the primary goals for treatment in a spasticity 
service.  Item reduction was achieved through consultation with a purposively-selected 
group of experienced physiotherapists and occupational therapists (n=16) in a 2-round 
Delphi process. This was followed by review of Delphi consultation findings by the 
Project Advisory Group (PAG) consisting of patients and carers.  
Results 
Development of the LegA included two rounds of Delphi consultation.  Further rounds 
were not required due to the high degree (80%) of agreement between respondents in 
rounds one and two.  From an initial shortlist of 126 items, 29 items were initially 
identified for inclusion in LegA, and subsequently refined to a 24-item (two sub-scales) 
tool consisting of 9 passive function sub-scale items and 15 active function sub-scale 
items.  The Delphi consultation ensured content validity, due to the experience of the 
clinicians in this area of practice and therefore appropriate reduction of items. In 
common with previous work in the upper limb, a 5-point ordinal scaling structure was 
chosen, with ratings based on activity over the preceding 7 days. 
Conclusions 
The LegA is designed to measure passive and active function following focal 
interventions for the paretic lower limb. Content and face validity have initially been 
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addressed within the development process. The next phase of development will involve 
formal evaluation of psychometric properties.  
Word count 250 
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Introduction 
In patients with acquired brain injury such as stroke or head injury, or other long term 
neurological conditions such as multiple sclerosis, lower limb spasticity (involuntary 
over-activity of muscle) can cause a diverse range of problems.  Its prevalence varies, 
but has been reported in 19-38% of patients after stroke 1, 2, and it has been highlighted 
as having a negative effect on both patients’ functional abilities, and on the ease with 
which others can care for them 3.  
 
Goals for the rehabilitation of patients with lower limb spasticity may therefore be to 
restore active function, for example balance, walking speed and gait pattern/quality if 
there is return of motor control, or to improve passive function and make it easier to 
care for the limb, for example maintaining perineal hygiene or assisting with dressing 4, 
if no return of motor control is likely 5. A comprehensive outcome measure therefore 
needs to assess both active and passive function to fully reflect the changes seen 
following therapeutic interventions 6.  The goals for treatment are therefore highly 
diverse, but are mostly contained within the domains of active and passive function. 
 
Interventions to manage lower limb spasticity are similarly complex and diverse. They 
include various combinations of medical treatments (systemic medications or botulinum 
toxin injections to relax muscles) and physical treatments (e.g. stretching, splinting, 
muscle strengthening and exercise etc.). In order to establish what types of intervention 
are most effective and cost-efficient for which patients, we need to record both inputs 
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(the type and amount of physiotherapy or other physical interventions) and outcomes 
(functional and other benefits for patients).   
 
The importance of measuring the impact of treatments on functional activity from the 
perspective of patients and their carers has been emphasised in Department of Health 
Guidance on the routine collection of Patient Reported Outcome Measures (PROMs).  
Tools used in clinical practice, need to be feasible for use in busy clinical settings and 
reflect performance in the real-life context as closely as possible.  PROMs reflect what 
patients actually do in their normal environment.  They therefore have advantages over 
clinic based tools, for example although tools such as the 10 meter walk test, reflect a 
patients’ capacity to walk 10 meters, they may not reflect what individual actually does 
outside test conditions. However, there is currently no comprehensive instrument to 
measure function in the context of the spastic lower limb, which may range from 
passive caring for the limb in severely disabled patients, to using the limb for active 
mobility in more able patients.  
 
In previous work we have developed a measure of upper limb passive and active 
function, the Arm Activity Measure 7-10. The ArmA was developed to evaluate outcome 
following upper limb rehabilitation interventions with a particular focus on spasticity.  
The current project was set up to develop and test an equivalent patient reported 
measure, the Leg Activity measure (LegA), for evaluating lower limb function, 
particularly following focal spasticity intervention.   
 
The objectives were:  
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1. To develop the LegA - a self-report measure for the assessment of both active 
and passive function in the paretic lower limb before and after rehabilitation 
interventions, and  
2. To evaluate face and content validity by investigating item relevance for 
professionals, patients and carers. 
 
Method 
Development of the Leg Activity Measure (LegA) comprised a multistage process.  
Initially items were identified from a previously published systematic review of lower 
limb functional assessment tools 11 and a retrospective review of goals set for spasticity 
intervention. Duplicate items were then removed and the remaining items then 
presented to specialist clinicians through a Delphi consultation process.  The project 
included a Project Advisory Group (PAG) consisting of patients and carers, who were 
then consulted on the findings from the Delphi process. See Figure 1 for the stages of 
LegA development.   
Insert Figure 1 about here. 
Ethical approval for re-evaluation of routinely collected data was granted by Harrow 
Research Ethics Committee (REC 04/Q0405/81).  Confirmation that NHS Research 
Ethics Approval was not required for the Delphi consultation with professionals was 
received. 
 
Goals Analysis 
The retrospective goals analysis had two aims, firstly identification of new items by 
patients and carers, secondly confirmation and supporting identification of items from 
the systematic review for potential inclusion in the new measure.  The methodology 
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used was based upon Ashford and colleagues work in using clinically set patient goals 
for PROM development 12. 
Setting: 
The goals analysed had been set during spasticity management intervention using 
botulinum toxin injection and physical therapy treatments.  To capture a broad range of 
patient experience the intervention and goal setting took place within a specialist hyper-
acute/sub-acute rehabilitation service and related specialist community service for 
patients with acquired brain injury and other complex neurological conditions.  
Procedure: 
Goals were set using the Goal attainment scaling (GAS) method, which scores the 
extent to which a patient’s individual goals are achieved in the course of intervention, so 
that diverse outcomes may be captured by a single system. Originally described by 
Kirusek and Sherman in the 1960s 13, GAS has been used in many areas of practice that 
warrant an individualised approach to outcome evaluation including rehabilitation 14, 15. 
It is increasingly used as a person-centred outcome measure in research evaluations of 
outcome following spasticity intervention 16-20, and is recommended as a method of 
recording patient-reported outcomes in guidelines for management of spasticity with 
Botulinum toxin 21.   
 
All goals are entered into the clinical database alongside intervention data. Goal 
statements were extracted from the database of routinely collected data. Goals were 
classified and mapped onto the WHO International Classification of Functioning (ICF) 
22-24 .  
Systematic review item classification 
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 Active function items representing the same issue but from different measurement tools 
identified in the systematic review were collapsed into the same item for consideration.  
This followed the same method undertaken for the items identified in the goals analysis. 
Passive function items were not identified in the systematic review. 
Delphi consultation 
Item selection and reduction was conducted in a 2-round Delphi consultation process 
with a group of purposively-selected expert clinicians (see Figure 1). The Delphi 
consultation was therefore used to establish the face and content validity for the LegA.  
Face validity is important because: 
1. It increases cooperation and motivation among respondents 
2. Attracts respondents  
3. Reduces dissatisfaction among respondents 
4. Makes it more likely that policy-makers and funders will accept findings  
(Nevo 1985) 
A closely related concept to face validity is content validity, which is similar, but 
evaluates that the instrument covers all the relevant concepts or domains (Streiner and 
Norman 2003).   
Participants and setting 
The purposive sample comprised expert clinicians, physiotherapists or occupational 
therapists, operating in specialist services offering spasticity management and 
botulinum toxin injection with concurrent therapy intervention.  They were identified 
from the ‘UK Adult Spasticity Forum’, the ‘UK Physiotherapy Injectors in spasticity’ 
and from the contacts of these professionals.  A requirement of inclusion was active 
involvement with spasticity management services or clinics both in providing 
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intervention (in the case of physiotherapists this included prescription and/or injection 
of botulinum toxin) and evaluating outcome. 
 
Participating clinicians worked in neurorehabilitation units across England.  An initial 
39 clinicians were approached and 21 agreed to participate and were recruited to the 
study.  However 5 clinicians did not respond to the first round of consultation and were 
then excluded.  The remaining 16 clinicians participated in both rounds of consultation.  
 
Procedure 
Delphi Consultation Round 1: Categorisation of collapsed items into single items 
from the goals analysis and systematic review was confirmed with Delphi participants 
in round 1. The consultation exercise then required respondents to judge the importance 
of possible items for inclusion in a PROM of function in the leg, for use following 
lower limb spasticity intervention (including botulinum toxin administration).  The 
items were presented in two separate sections of active function and passive function.   
 
Respondents were then asked to:  
(a) Rank the frequency the item was addressed as a goal in rehabilitation intervention;  
(b) Rank the difficulty of the item (for patient achievement);  
(c) List any items that were not already included which they considered to be of 
particular importance, explaining their reasons for inclusion.   
After the comments had been returned, and participants contacted if necessary to clarify 
any points, the initial list of items was revised and a short list of items was produced for 
round 2. 
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Delphi Consultation Round 2: The short list was then returned to the same experts for 
their further comment and verification, again asking them to identify items for inclusion 
and exclusion with stated reasons.   
 
Item confirmation through PAG consultation:  
The PAG was asked to review the results of the Delphi consultation.  Four patient and 
carer dyads participated in the consultation meeting and commented on the findings.  
The PAG were given the questions that the Delphi participants had been presented with 
and were then asked to comment on: 
(a) Deficiencies in the process 
(b) Any items that had been missed and not considered 
(c) Any items that had been excluded which they felt were not justified. 
Responses from the PAG were then discussed with the lead researcher (SA), and 
solutions or additions were identified. 
 
Pilot testing: 
The LegA was then plot tested in routine clinical practice with individuals undergoing 
focal spasticity intervention, including botulinum toxin administration and physical 
interventions. 
 
Results  
Goals Analysis 
In the analysis 125 goals were identified from the records of 62 patients who had 
received focal spasticity intervention and six distinct categories of goal were identified. 
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These were: pain, involuntary movement, range of movement, mobility, passive 
function and active function as shown in figure 2 and table 1.    
Insert Figure 2 about here. 
Insert Table 1 about here 
Identified goals were then ‘mapped’ to ICF codes 22, 24, after the method applied by 
Turner-Stokes 18 (See table 2. 
Insert Table 2 about here  
Systematic review item classification 
The systematic review initially identified 111 possible active function items, taken from 
7 measurement tools.  These initial items were then collapsed into categories (with 
duplicate items also removed) resulting in 16 possible new items. 
 
The resultant list of active function items and their representation in the systematic 
review identified pre-existing PROM’s is presented in table 3. 
Insert Table 3 about here 
Delphi Consultation  
Round 1 Delphi consultation resulted in an initial selection of measurement items within 
the domains of active and passive function only as per the study aims.  There was no 
disagreement with the categorisation of passive or active function items taken from the 
goals analysis and systematic review. Table 4 shows the initial items selected after 
round 1 of consultation.   
Insert Table 4 about here 
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Table 4 presents the rank frequency with which an item had been addressed or set as an 
intervention goal in practice by respondents, and the rank ‘difficulty’ of the item for 
patients to perform.   
Insert Table 5 about here 
In table 5 the items removed have also been indicated (marked with *) as well as those 
added from round 1 (indicated in ‘bold’).  Four items were removed in round 2 Delphi 
consultation, these were: ‘cleaning the foot’, ‘cutting toe nails’, ‘catheterisation’, and 
‘spasms impacting on comfort or sleep’. The items ‘positioning the legs’ and ‘bed 
positioning’ were combined into a single item.  Given the consistency of respondents’ 
responses and the consensus identified further rounds of consultation were not 
undertaken.  
Project Advisory Group (PAG) consultation  
The results of the Delphi consultation were reported to the PAG, consisting of four 
patient and carer dyads.  No changes to items were suggested, but some comments were 
made on question wording which were then included in the final list of items (see 
Figure 3). 
Insert Figure 3 about here 
They included suggestions for wording questions in a manner more easily understood 
by patients and carers.  For example the question about perineal hygiene was modified 
to ‘cleaning and washing the area between your legs’.  It is anticipated that these small 
modifications to the wording and presentation of questions will aid consistency of 
responses when undertaking the psychometric evaluation of the measure developed. 
 
Involvement of patients and carers in the PAG played an important part in measure 
development and was highly valued, as expressed by one member: 
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“Having participated in a pilot for the Leg Activity measure, I have observed 
how straightforward, simple and seamless it was to contribute to as a patient with 
experience. I am convinced this pioneering measurement will provide an important 
development in the consistent assessment of spastic lower limbs; it will have a valuable 
impact on guidance in respect of rehabilitation input, thus improving function in daily 
life.” 
 
Pilot testing 
The LegA was pilot tested by 16 patients (and their carers when relevant) undergoing 
rehabilitation intervention for lower limb activity limitations requiring the management 
of spasticity.  Passive function sub-scale scores ranged from 1 to 23 and active function 
scores ranged from 11 to 60. Five patients had repeated measurement after intervention 
and showed changes on both sub-scales.  In general the pilot group had significant 
functional impairment reflected in the active function limitation recorded by LegA. 
 
The scale structure for the LegA is taken from that used in the previously developed 
ArmA and also used in other patient reported tools.  The application of the same scale 
presentation maintains consistency of the tools and should aid clinicians in the 
application of LegA. The final measure, which now warrants formal psychometric 
testing, consists of two domains, active and passive function.  Passive function contains 
9 items.  Active function contains 15 items.  A summary of the changes to items 
through the different stages of development can be seen in Figure 1.   
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Discussion 
This project and process of development built on our previous and on-going work in 
developing a patient reported measure of arm activity, the Arm Activity (ArmA), for 
evaluating spasticity intervention in the upper limb (Ashford et al. 2013; Ashford et al. 
2013c; Ashford and Turner-Stokes 2013d; Ashford et al. 2014).  The model of 
development for ArmA was modified to develop the LegA.  Delphi consultation was 
used again for LegA development because of its strengths in utilising experts in an 
unbiased manner throughout the entire process of development 25.  Finger and 
colleagues consider the Delphi method to have four key characteristics: anonymity for 
those participating; iteration of concepts; statistical group response based on frequency 
of selections (in this instance item selection); and informed input from expert 
participants 26.  These characteristics are particularly relevant in using expert clinicians 
to develop a measure of functional outcome.  
 
The development of the LegA included two rounds of Delphi consultation.  Further 
rounds of consultation were not required due to the high degree of agreement between 
respondents in rounds one and two.  The resulting 24-item (two sub-scales) tool consists 
of 9 passive function sub-scale items and 15 active function sub-scale items.  The 
Delphi consultation ensured content validity, due to the experience of the clinicians in 
this area of practice and therefore appropriate reduction of items.  This was in addition 
to the initial process of item selection and input in the process of development and 
review of findings by the PAG.  Face validity was address through selection of goal 
based items by patients and carers, Delphi consultation with clinicians and confirmed by 
the review of patient and carer members of the PAG. 
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Delphi consultation has the advantages of providing anonymity to participants and 
reducing personality based influences such as the impact of socially dominant 
individuals on the consensus process 26, 27.    The literature provides no definitive 
recommendation on panel size, which have ranged greatly in different studies between 
10 and 1685 28 and in the rehabilitation literature from 15 29 to 263 26.  Raine suggests 
that good results can be obtained with between 10 and 15 panel participants where the 
group is homogenous, and that smaller groups such as this are also more likely to retain 
group members 29.  Hsu and Sandford (2007) recommend that approximately 15 
subjects maybe an appropriate number where again the participants are homogenous.  
 
Some limitations to the current work are however apparent. Firstly the selection of the 
measurement items was primarily based on the judgement of clinical experts and not 
patients and carers.  Patient selected items were included alongside the literature at the 
start of the process and the PAG reviewed the outcomes of the Delphi consultation at 
the end of the process.  Nevertheless direct involvement of patients and carers in item 
selection could have been considered further.  Secondly the size of the Delphi panel, 
though within the range of recommendations by other authors, could still be considered 
quite small.  There is a possibility that had the group been larger, different results may 
have been obtained.  However, this is unlikely given the consistency of findings and the 
need for only two rounds of consultation. Sample size was also a potential limitation for 
the goals analysis, but was a reflective sample of the population of interest. 
 
The LegA is a measure of difficulty in passive and active function for application 
following focal therapy intervention and in particular for spasticity (botulinum toxin and 
physical) interventions.  The active and passive sub-scales of the tool are treated as 
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separate constructs, which nevertheless are related and are both important to the 
achievement of clinically relevant goals.  The LegA is therefore likely to have utility in 
practice for evaluation of spasticity intervention (often for passive function) and 
possibly other focal interventions such as task practice training for active function 
improvement.  The LegA is unique in addressing these constructs and, being patient 
reported, evaluates function in a ‘real life’ context. 
 
In conclusion, 1) a measure for lower limb active and passive function was developed 
and 2) the Delphi method confirmed the content and face validity of the LegA.  This has 
resulted in a measure which now warrants psychometric testing.  The process of item 
selection, reduction and confirmation was comprehensive and while limitations to the 
methodology are present, the overall process had a high degree of rigour, ensuring 
confidence in the content validity of the LegA measure.  Its psychometric properties 
(construct validity, internal consistency, unidimensionality, reproducibility and 
feasibility) will now undergo preliminary evaluation. 
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Clinical Messages 
 This study describes the systematic development of the Leg Activity measure 
(LegA), the first measure of active and passive function in the paretic lower 
limb. 
 The Leg Activity (LegA) measure has been developed with demonstrated face 
and content validity.   
 The LegA is theoretically appropriate for clinical application and is undergoing 
psychometric testing to demonstrate this. 
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Table 1: Breakdown of goals set for all patients (125 goals in 62 patients) in each goal area 
 
Goal Domain Goal area No. of goals 
set 
Percentage 
of goals set 
Body structure and function N=45 goals 
(32 %) 
Spasticity-related pain or discomfort 10 8 
Range of movement, prevention of contractures/ deformity 32 25.6 
Involuntary movements during use of other limbs (associated reactions) or 
spasms  
3 2.4 
Activities and participation 
N=80 goals (64 %) 
Passive function - Ease of caring for the affected limb  
(e.g. maintaining hygiene, skin integrity, dressing the limb, resting splint 
use and application) 
51 40.8 
Active function  - Using the limb in an active function task  
(e.g. functional splint use and application) 
15 12 
Improved mobility  
(e.g. transfers, standing, walking, balance, confidence, avoiding falls) 
12 9.6 
Therapy facilitation 2 1.6 
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Table 2: Mapping of main goal categories onto the relevant World Health Organisation ICF codes according to Turner-Stokes et al 2010  
 
Domain  Goal area Chapter Primary ICF Code Associated ICF codes 
 
Body structure and function 
   
  Pain 2 - Sensory& Pain b280 - Pain b735 
  
 
Passive range of movement 
 
7- Neuro-
musculoskeletal b735 - Muscle tone b710 
  
 
Reducing associated 
reactions 
7- Neuro-
musculoskeletal 
b755 - Involuntary movement 
reactions to position/balance b735 
       
Activity and participation    
     
 Maintaining postures 4- Mobility d415 - Maintaining body position d445 
  
Improved walking / gait 
pattern 4- Mobility d450 - Walking d420 
 Transferring 4- Mobility d420 - Transferring d410, d415 
  Changing position 4- Mobility d410 – Changing body position d415, d420 
       
 General Independence 5- Self care d500 - General Independence b510-washing 
  Hygiene /skin integrity 5- Self care d520 - Caring for body parts b735, b710, b510 
 Caring for the leg  5- Self care d520 - Caring for body parts b735, b710, b510 
  Dressing 5- Self care d540 - Dressing d440, b735, d710 
       
ICF: International classification of functioning disability and heal
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Table 3 Items identified through the systematic review following categorisation and the tools from which they originated. 
 
Active Function BICRO CSQ HAP LEFS N-ADL RMI SIS 
Turning in bed        
Lying to sitting        
Sitting        
Transfer (bed to chair)        
Transfer (Bath or car)        
Sit to stand        
Standing        
Walking indoors        
Stairs        
Picking object off floor        
Walking outdoors (even ground)        
Walking outdoors (uneven ground)        
Running        
Jumping / hopping        
Endurance (Walking half a mile)        
Endurance (running half a mile)        
Brain Injury Community Rehabilitation Outcome Scales (BICRO), Climbing Stairs Questionnaire (CSQ), Human Activity Profile (HAP), Lower 
Extremity Functional Scale (LEFS), Nottingham Extended ADL Index (N-ADL), Rivermead Mobility Index (RMI), Stroke Impact Scale (SIS). 
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Table 4 Round 1 Delphi consultation initial item short list and rankings 
 
Frequency item addressed in practice – Relevance of item 
Item  Mean SD Mode Median 
Passive Function 
Bed positioning 2.3 1.9 1 1.5 
Cleaning the foot 9.6 1.8 10 10 
Cutting toe nails 10.3 0.7 11 10 
Cleaning behind the knee 8.2 2.0 9 9 
Wheelchair positioning 2.7 1.6 3 2.5 
Catheterisation 7.2 2.1 6 7 
Perineal hygiene 3.8 1.7 3 3.5 
Splint application (AFO or Knee splint) 5.2 2.6 9 5.5 
Positioning the legs (using pillow or positioning aid) 3.4 1.4 4 4 
Putting on underwear or continence pads 6.2 1.9 7 7 
Lower limb dressing (e.g. putting limb through trouser leg) 6.9 1.6 8 7.5 
Active Function 
Turning in bed 6.2 4.5 1 6 
Lying to sitting 6.8 3.4 7 7 
Sitting 5.6 4.6 3 3.5 
Transfer (bed to chair) 3.7 1.9 4 4 
Transfer (Bath or car) 8.6 2.1 10 8.5 
Sit to stand 3.6 2.4 1 3 
Standing 4.3 4.1 2 3 
Walking indoors 6 3.6 4 5.5 
Balance (standing, walking, turning) 6.6 3.0 5 7 
Stairs 9.4 2.2 9 9.5 
Walking around obstacles 12.1 1.1 12 12 
Walking over carpet 10.7 3.4 12 11 
Walking outdoors 10.9 2.8 13 11.5 
Walking outdoors over uneven ground 12 3.1 14 14 
Running 15.2 1.8 16 16 
Jumping / hopping 16.3 1.9 17 17 
Endurance (Walking half a mile) 15.4 1.5 15 15 
Endurance (running half a mile) 17.4 1.0 18 18 
Active Function items not included in ranking and removed: up and down 4 steps, 
picking (object) off the floor, bicycling, fluidity of walking (gait pattern) and 
hopping. 
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Table 5 Round 2 Delphi consultation item assignment 
 
Mean rank: Difficulty of item 
Passive Function 
1 Perineal hygiene 
2 Splint application (AFO or Knee splint) 
3 Wheelchair positioning 
4 Lower limb dressing (e.g. putting limb through trouser leg) 
5 Enable hoist transfer (including sling insertion) 
6 Catheterisation* 
7 Putting on underwear or continence pads 
8 Bed positioning (including positioning legs using pillow or positioning aid) 
9 Cleaning behind the knee 
10 Putting on shoes 
11 Spasms impacting on comfort or sleep* 
Active Function 
1 Turning in bed 
2 Lying to sitting 
3 Transfer (bed to chair) 
4 Sitting 
5 Transfer (Bath or car) 
6 Sit to stand 
7 Standing 
8 Walking indoors 
9 Turning around 
10 Balance (standing, walking, turning)*Modified, balance included in other items 
11 Stairs 
12 Walking around obstacles 
13 Walking over carpet 
14 Walking outdoors 
15 Walking outdoors over uneven ground 
16 Jumping / hopping* 
17 Running* 
18 Endurance (Walking half a mile) 
19 Endurance (running half a mile)* 
Items in ‘bold’ were added after round 1. Items with * were removed after round 
2. 
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Figure 1 Summary of item reduction for the LegA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 
selection 
Delphi 
consultation 
PAG 
Confirmation 
Systematic review: 
(111 possible items)  
 
Following item categorisation: 
(0 Passive function)  
(16 Active function) 
 
Goal Analysis:   
(125 possible items) 
 
Following item categorisation:  
(8 Passive function)  
(7 Active function) 
 
 
 
Candidate items: 31 Items 
 
(23 Active function)   (8 Passive function) 
   
 
Delphi Consultation 1 
Consultation with clinicians  
n = 16 
(11 Passive function) 
(19 Active function) 
 
Items excluded   
Not prioritised by 
clinicians 
(0 Passive function)  
(5 Active function) 
 
 
Delphi Consultation 2 
Consultation with clinicians  
n = 16 
(9 Passive function) 
(15 Active function) 
 
LegA  
(9 Passive function) 
(15 Active function) 
Item confirmation 
Patients & carers 
n = 4 dyads 
(9 Passive function) 
(15 Active function) 
 
Additional 
items 
Identified by 
clinicians: 
(3 Passive) 
(1 Active) 
 
Items excluded   
Not prioritised by 
clinicians 
(2 Passive function) 
(4 Active function) 
 
 
Pilot testing Pilot testing  
Patients and carers (n = 16) 
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Figure 2 Categories of goal set and achieved 
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Figure 3: Leg Activity measure items 
 
  
Difficulty for each item is scored over the preceding 7 days as follows: 
 
0 = no difficulty 
1 = mild  
2 = moderate  
3 = severe difficulty  
4 = Unable to do activity 
 
   Section A  
 
1. Cleaning and washing the area between your legs 
2. Putting on a splint (If never done circle 0)  
3. Positioning legs in a wheelchair (If never done circle 0) 
4. Putting your leg(s) through a trouser leg(s) (If never done circle 0) 
5. Transfer using a hoist, including positioning sling     
(If never done circle 0) 
6. Putting on underwear or continence pads 
7. Positioning your leg(s) in bed using a positioning aid or 
pillow (If never done circle 0) 
8. Cleaning behind your knee (knees) 
9. Putting on your footwear  
   Section B  
 
1. Turning in bed 
2. Moving from lying to sitting 
3. Being able to sit (including balance) 
4. Transferring from bed to chair or wheelchair 
5. Transferring from wheelchair to car 
6. Moving from sitting to standing (including balance) 
7. Standing (including balance) 
8. Walking indoors (including balance) 
9. Turning around (including balance) 
10. Walking up stairs  
11. Walking around obstacles or objects (including balance) 
12. Walking over carpet  
13. Walking outdoors  
14. Walking over rough or uneven ground outdoors 
15. Walking for half a mile or more 
 The LegA tool is available from: http://www.csi.kcl.ac.uk/tools.html  
